CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-02 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Restricted Stock Unit | +23,000 | 23,000 | ||
| 2020-01-02 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Option - Right to Buy | −57,000 | 57,000 | ||
| 2020-01-02 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Restricted Stock Unit | −23,000 | 23,000 | ||
| 2020-01-02 | BAUM MARK L Chief Executive Officer | Grant or award · Option - Right to Buy | −217,500 | 217,500 | ||
| 2020-01-02 | BAUM MARK L Chief Executive Officer | Grant or award · Restricted Stock Unit | −88,000 | 88,000 | ||
| 2019-11-22 | BOLL ANDREW R. Chief Financial Officer | Option exercise | +39,000 | $1.79 | $70K | 123,000 |
| 2019-11-22 | BOLL ANDREW R. Chief Financial Officer | Option exercise · Purchase Warrant | −39,000 | 0 | ||
| 2019-11-22 | BAUM MARK L Chief Executive Officer | Option exercise | +156,000 | $1.79 | $279K | 598,126 |
| 2019-11-22 | BAUM MARK L Chief Executive Officer | Option exercise · Purchase Warrant | −156,000 | 0 | ||
| 2019-11-11 | Kammer Robert J Director | Sale | −6,500 | $4.75 | $31K | 797,327 |
| 2019-10-07 | Kammer Robert J Director | Sale | −6,500 | $5.25 | $34K | 803,827 |
| 2019-09-09 | Kammer Robert J Director | Sale | −6,500 | $5.67 | $37K | 810,327 |
| 2019-08-12 | Kammer Robert J Director | Sale | −6,500 | $6.89 | $45K | 816,827 |
| 2019-07-15 | Kammer Robert J Director | Sale | −6,500 | $7.91 | $51K | 823,327 |
| 2019-06-26 | Principi Anthony Director | Grant or award · RSU | +9,715 | 9,715 | ||
| 2019-06-26 | Kammer Robert J Director | Grant or award · RSU | +9,715 | 9,715 | ||
| 2019-06-26 | LINDSTROM RICHARD L MD Director | Grant or award · RSU | +9,715 | 9,715 | ||
| 2019-06-26 | AUSTIN STEPHEN G Director | Grant or award · RSU | +9,715 | 9,715 | ||
| 2019-06-03 | Kammer Robert J Director | Sale | −10,000 | $5.78 | $58K | 829,827 |
| 2019-05-01 | Kammer Robert J Director | Sale | −10,000 | $4.57 | $46K | 839,827 |
Page 13 of 17 · 336 trades